Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 14/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 12/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7811397 | 1.00 | CHRM1 (0.42) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| SCHEMBL231364 | 1.00 | CHRM1 (0.42) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL6169933 | 0.98 | ALDH1A1 (0.43) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| Hydrochloric Acid SCHEMBL7701666 | 0.98 | ALDH1A1 (0.43) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| SCHEMBL14033267 | 0.92 | CHRM1 (0.39) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| Carbamic Acid SCHEMBL7831823 | 0.88 | ALDH1A1 (0.42) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| Carbamic Acid SCHEMBL7831819 | 0.88 | ALDH1A1 (0.42) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| SCHEMBL14033833 | 0.86 | CHRM2 (0.33) | CHRM1CHRM2CHRM3CHRNB2CHRNA4 | |
| SCHEMBL7811134 | 0.86 | — | — | |
| SCHEMBL7818558 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116789971-A | Preparation method and application of normal-temperature self-healing antifouling resin containing double antifouling factors | 浙江省海洋开发研究院 | 2023-09-22 | — | — | CN | claimed |
| EP-2209783-B1 | NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINE DERIVATIVES AND THEIR MEDICAL USE | ANIONA APS (DK) | 2016-03-16 | — | — | EP | disclosed |
| US-8986654-B2 | Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use | DANPET AB (SE) | 2015-03-24 | — | — | US | disclosed |
| US-8946412-B2 | Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators | DANPET AB (SE) | 2015-02-03 | — | — | US | disclosed |
| US-8778928-B2 | Indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use | DANPET AB (SE) | 2014-07-15 | — | — | US | disclosed |
| US-20140030190-A1 | LABELLED AND UN-LABELLED METHYL-PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE | DANPET AB (SE) | 2014-01-30 | — | — | US | disclosed |
| US-8372832-B2 | 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use | NEUROSEARCH A/S (DK) | 2013-02-12 | — | — | US | disclosed |
| US-20130004428-A1 | DIAZABICYCLONONYL OXADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | NEUROSEARCH A/S (DK) | 2013-01-03 | — | — | US | disclosed |
| US-8343960-B2 | 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use | NEUROSEARCH A/S (DK) | 2013-01-01 | — | — | US | disclosed |
| US-20120288443-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | NEUROSEARCH A/S (DK) | 2012-11-15 | — | — | US | disclosed |
| US-20040127491-A1 | Novel diazabicyclic biaryl derivatives | ANIONA APS (DK) | 2004-07-01 | — | — | US | disclosed |
| WO-2004043960-A1 | 1,4-DIAZABICYCLO (3,2,2)NONANE DERIVATIVES, PREPARATION AND THERAPEUTICAL USE THEREOF | NEUROSEARCH A/S (DK) | 2004-05-27 | — | — | WO | disclosed |
| WO-2004029053-A1 | NOVEL 1,4-DIAZABICYCLOALKANE DERIVATIVES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 2004-04-08 | — | — | WO | disclosed |
| EP-1211940-A1 | AZABICYCLO AND AZACYCLO OXIME AND AMINE COMPOUNDS AS PESTICIDES | Aventis CropScience GmbH (DE) | 2002-06-12 | — | — | EP | disclosed |
| EP-0764165-B1 | PREPARATION OF STEREOCHEMICALLY PURE OXIMES WITH MUSCARINIC ACTIVITY | WARNER LAMBERT CO (US) | 2001-11-07 | — | — | EP | disclosed |
| WO-2001015532-A1 | AZABICYCLO AND AZACYCLO OXIME AND AMINE COMPOUNDS AS PESTICIDES | AVENTIS CROPSCIENCE GMBH (DE) | 2001-03-08 | — | — | WO | disclosed |
| US-5679673-A | ANTICERBERAL ISCHEMIA, ANTIPSYCHOTIC AND ANTICONVULSION AGENT | THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-10-21 | — | — | US | disclosed |
| EP-0764165-A1 | PREPARATION OF STEREOCHEMICALLY PURE OXIMES WITH MUSCARINIC ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1997-03-26 | — | — | EP | disclosed |
| WO-1995034562-A1 | PREPARATION OF STEREOCHEMICALLY PURE OXIMES WITH MUSCARINIC ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1995-12-21 | — | — | WO | disclosed |
| US-4675326-A | MONO AND BIS-PYRIDINIUM OXIMES FOR ORGANOPHOSPHOROUS AND CARB AMATE POISONING | STATE OF ISRAEL, PRIME MINISTERS OFFICE, ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH | 1987-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120288443-A1 | LABELLED PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR USE IN DIAGNOSTIC METHODS | GRM3, SSTR3, OXGR1 | CHRM1 1301/4885CHRM2 1359/4885CHRM3 500/4885 |
| US-20140030190-A1 | LABELLED AND UN-LABELLED METHYL-PYRROLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE | GRM3, CNR1, CNR2 | CHRM1 275/4885CHRM2 318/4885CHRM3 162/4885 |
| US-20130004428-A1 | DIAZABICYCLONONYL OXADIAZOLE COMPOUNDS AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS | CHRNA3, CHRNA1, CHRNA5 | CHRM1 27/4885CHRM2 34/4885CHRM3 19/4885 |
| US-20040127491-A1 | Novel diazabicyclic biaryl derivatives | CHRNA6, CHRNA3, CHRNA2 | CHRM1 47/4885CHRM2 24/4885CHRM3 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.